OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$11.12 USD
-0.17 (-1.51%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $11.06 -0.06 (-0.54%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum C VGM
Brokerage Reports
OptimizeRx Corp. [OPRX]
Reports for Purchase
Showing records 41 - 60 ( 124 total )
Company: OptimizeRx Corp.
Industry: Computer - Software
RFP Acceleration Makes 2022 Forecast Possible to Hit in 2021; PT to $70
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Real World Evidence Multiplies Real World Revenue Opportunities
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
3Q20 Above Raised Expectations; RFP Pipeline Roughly Doubling Strong 2019
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Panel Discussion: eHealth: COVID Digital Dynamics - Distortions - Drivers
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Pre-Announced Growth Upside Supports Bullish Breakout Outlook
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Faster Growth View Triangulated; Increasing Estimates Drive PT To $40.00
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Enterprise Growth Momentum Keeps Building; Reiterate Buy Rating - $30 PT
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Sector Earnings Preview for "Super Thursday" - May 7th
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Growth Acceleration - Demand Drivers Bode Well for Outlook; Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Good Defensibility - Improving Prospect Outlook Expected In 1Q20 Results
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Return To Growth Drives Record Revenues; 2020 Catalysts Mounting
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R